1. Home
  2. FUBO vs NBTX Comparison

FUBO vs NBTX Comparison

Compare FUBO & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUBO
  • NBTX
  • Stock Information
  • Founded
  • FUBO 2009
  • NBTX 2003
  • Country
  • FUBO United States
  • NBTX France
  • Employees
  • FUBO N/A
  • NBTX N/A
  • Industry
  • FUBO Broadcasting
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FUBO Industrials
  • NBTX Health Care
  • Exchange
  • FUBO Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • FUBO 1.4B
  • NBTX 1.3B
  • IPO Year
  • FUBO 2020
  • NBTX 2020
  • Fundamental
  • Price
  • FUBO $3.69
  • NBTX $17.99
  • Analyst Decision
  • FUBO Buy
  • NBTX Strong Buy
  • Analyst Count
  • FUBO 4
  • NBTX 1
  • Target Price
  • FUBO $5.35
  • NBTX $8.00
  • AVG Volume (30 Days)
  • FUBO 15.1M
  • NBTX 140.7K
  • Earning Date
  • FUBO 11-03-2025
  • NBTX 09-30-2025
  • Dividend Yield
  • FUBO N/A
  • NBTX N/A
  • EPS Growth
  • FUBO N/A
  • NBTX N/A
  • EPS
  • FUBO 0.26
  • NBTX N/A
  • Revenue
  • FUBO $1,625,738,000.00
  • NBTX $11,930,711.00
  • Revenue This Year
  • FUBO N/A
  • NBTX N/A
  • Revenue Next Year
  • FUBO $6.48
  • NBTX $114.97
  • P/E Ratio
  • FUBO $14.11
  • NBTX N/A
  • Revenue Growth
  • FUBO 6.65
  • NBTX N/A
  • 52 Week Low
  • FUBO $1.21
  • NBTX $2.76
  • 52 Week High
  • FUBO $6.45
  • NBTX $30.35
  • Technical
  • Relative Strength Index (RSI)
  • FUBO 45.39
  • NBTX 45.73
  • Support Level
  • FUBO $3.49
  • NBTX $14.78
  • Resistance Level
  • FUBO $3.71
  • NBTX $28.51
  • Average True Range (ATR)
  • FUBO 0.23
  • NBTX 2.11
  • MACD
  • FUBO -0.01
  • NBTX -1.51
  • Stochastic Oscillator
  • FUBO 31.87
  • NBTX 21.49

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: